©The Author(s) 2025.
World J Gastrointest Surg. Oct 27, 2025; 17(10): 108938
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.108938
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.108938
Table 1 Patient demographics and comorbidities
| Variable | Non-operated (n = 15) | Operated (n = 15) | P value |
| Age (year), mean ± SD | 87.1 ± 6.2 | 76.1 ± 7.4 | < 0.001 |
| Male sex (%) | 60.00% | 73.30% | 0.493 |
| Diabetes mellitus (%) | 30.80% | 73.30% | 0.024 |
| Ischemic heart disease (%) | 38.50% | 50.00% | 0.547 |
| Chronic kidney disease (%) | 35.70% | 26.70% | 0.599 |
| Interstitial COPD (%) | 30.80% | 6.70% | 0.097 |
- Citation: Mazarieb M, Parvaiz A, Hawashna U, Romanenko Y, Atar E, Bachar GN. Minimally invasive management of acute perforated cholecystitis: The role of percutaneous transhepatic cholecystostomy. World J Gastrointest Surg 2025; 17(10): 108938
- URL: https://www.wjgnet.com/1948-9366/full/v17/i10/108938.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i10.108938